Skip to main content
. 2015 Apr 18;29:199.

Table 3 . Quality of life (QOL) assessment with MQ and SF-36 measures .

TA group (n= 38) PG group (n=38) ***p
Before
treatment
mean (SD)
After
treatment
mean (SD)

Mean
difference
Before
treatment
mean (SD)
After
treatment
mean (SD)

Mean
difference
Menorrhagia Questionnaire (score) 47.6 (16.72) 23.95
(13.78)*
23.61 42.05 (13.77) 19.84 (10.18)** 22.2 0.14
SF-36 Questionnaire (score) 
Physical 
   Health
Physical functioning 79.1 (14.65) 83.7
(11.83)*
4.60 79.2 (13.00) 80.1 (11.88) 0.92 0.19
Role-physical 50.6 (28.76) 62.5
(21.55) *
11.84 56.6 (27.63) 61.2 (27.69) ** 4.6 0.87
Bodily pain 58. 4 (24.33) 60.3
(21.87)
1.84 60.0 (20.53) 66.3 (19.64)** 6.31 0.20
General health 54.5 (19.98) 67.3
(14.84)*
12.78 50.6 (20.19) 57.0 (19.93)** 6.36 0.01
Mental
   Health
Vitality 47.63
(23.29)
63.5
(15.72)*
15.92 46.6 (20.66) 61.0 (17.05)** 14.47 0.50
Social functioning 67.4 (20.66) 75.3
(13.78) *
7.89 64.1
(15.42)
78.0 (12.13)** 13.81 0.40
Role-emotional 51.7 (33.51) 59.6
(23.45) *
7.89 57.9 (29.69) 63.1 (27.71) ** 5.2 0.48
Mental health 61.0 (25.00) 74.1
(15.69)*
13.05 63.0
(23.66)
70.4 (17.51)** 7.36 0.33

* p< 0.001 compared with TA before treatment (Paired t test)

** p< 0.001 compared with golnar group before treatment (Paired t test)

***p after treatment comparison of TA and PG groups(t test)